在体内基质编辑可减少自体主导多囊性病的肝囊

Antonia Ibel1, Rishi Bhardwaj2, Duygu Elif Yilmaz3

  • 1Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Nephrology and Medical Intensive Care, Charitéplatz 1, 10117 Berlin, Germany; BIMSB, Max Delbrück Center for Molecular Medicine in the Helmholtz Association, 10115 Berlin, Germany.

概括

在细胞和小鼠中精确纠正引起疾病的PKD1变异. 这种基因组编辑方法减少了肝囊,为自身主导多囊性病 (ADPKD) 提供了新的治疗希望.